Skip to main content
SpringerLink
Log in

The US FDA has been criticised for its handling of the investigation into the contaminated heparin crisis.*

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Tanne JH.FDA breached integrity over investigation of contaminated heparin. BMJ 341: [3 pages], 16 Nov 2010. Available from: URL: http://dx.doi.org/10.1136/bmj.c6529

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The US FDA has been criticised for its handling of the investigation into the contaminated heparin crisis.*. React. Wkly. 1329, 4 (2010). https://doi.org/10.2165/00128415-201013290-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013290-00006

Keywords

Search

Navigation